Nasdaq Issues Delisting Warning to Adagio Medical Over Sub-$1.00 Stock Price
ADGM is trading near its 52-week low of $0.7 (14% above the low) on light trading volume (0.3× avg).
Summary
Adagio Medical received a delisting warning from Nasdaq for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. This follows the 8-K filed today disclosing the same warning. The company, which has a 'going concern' warning and significant cash burn, now has 180 days to regain compliance, potentially via a reverse stock split. Failure to meet this requirement could lead to delisting, further complicating its ability to raise capital and maintain investor confidence. The deadline to regain compliance is December 9, 2026.
At the time of this announcement, ADGM was trading at $0.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.70 to $2.58. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.